SomnoMed Limited (SOMNF)

Market Cap	58.06M
Revenue (ttm)	62.04M
Net Income (ttm)	-3.71M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,500
Average Volume	8,332
Open	0.3750
Previous Close	0.4014
Day's Range	0.3675 - 0.3852
52-Week Range	0.1300 - 0.4400
Beta	1.05
RSI	45.43
Earnings Date	May 29, 2025

About SomnoMed

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper te...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 300
• Stock Exchange: OTCMKTS
• Ticker Symbol: SOMNF

Financial Performance

In 2024, SomnoMed's revenue was 91.65 million, an increase of 9.61% compared to the previous year's 83.62 million. Losses were -12.24 million, 53.0% more than in 2023.

Financial numbers in AUD